Patient Guide
How Embody Works
Understand Embody's intake, provider review, support model, and shipping flow before you choose between the semaglutide and tirzepatide paths.
This hub is the orientation layer for visitors who want the program explained before they click into a treatment-specific page. It makes the handoff from intake to provider review to delivery easier to follow.
- What happens after I complete Embody's intake?
- Who actually reviews the case and decides whether treatment is appropriate?
- What does the support and delivery flow look like if I am approved?
Semaglutide GLP-1 Injections
Review Embody's weekly semaglutide injection path, including what the intake covers, how provider review works, and what to expect before delivery.
Tirzepatide GLP-1 / GIP Injections
Explore Embody's weekly tirzepatide path, including how the intake works, what provider review covers, and how the higher-intensity option is framed.
Visitors begin with a short online intake that gives the provider the baseline information needed for an initial review.
A licensed provider reviews the submission and determines whether a semaglutide or tirzepatide path should move forward.
If treatment is approved, prescription handling, shipping, and ongoing support move into the active care workflow.
Transparency Links